NPCE Q4 2025 Earnings — NeuroPace, Inc. Revenue & Financial Results | Market Cap Arena

NPCENeuroPace, Inc.

$482M

Q4 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$27M+23.9% YoY

Gross Profit

$21M77.4% margin

Operating Income

-$2M-6.6% margin

Net Income

-$13M-49.6% margin

EPS (Diluted)

$-0.08

QoQ Revenue Growth

-2.8%

Cash Flow

Operating Cash Flow

$506,000

Free Cash Flow

$506,000

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$106M

Total Liabilities

$87M

Stockholders' Equity

$19M

Cash & Equivalents

$22M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$27M	$21M	+23.9%
Gross Profit	$21M	$16M	+27.1%
Operating Income	-$2M	-$4M	+51.6%
Net Income	-$13M	-$5M	-151.0%

Geographic Segments

Non-US

$400,000100%